Teva Continues Restructuring With 46 Cuts in Pennsylvania Post author:Sam Post published:February 7, 2018 Post category:BioPharma The cuts were apparently announced in late January with a WARN notice filed with the state. Source: BioSpace You Might Also Like The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) September 28, 2017 DxTerity Collaborates With On The Development Of A Cancer Genomic Blood Test To Predict Response To Radiation Therapy September 21, 2017 FDA Rejects Agile's Contraceptive Patch Twirla For a Second Time December 21, 2017
The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) September 28, 2017
DxTerity Collaborates With On The Development Of A Cancer Genomic Blood Test To Predict Response To Radiation Therapy September 21, 2017